Harms of synthetic cannabinoid receptor agonists (SCRAs) and their management
Guardat en:
Abdulrahim, D., Bowden-Jones, O., Harms of synthetic cannabinoid receptor agonists (SCRAs) and their management. Earls Court, Novel Psychoactive Treatment UK Network, 2016, 22 p.
Ref.
514552
Localització:
SIIS Archivo
Palabras clave:
Drogodependencias, Drogas ilegales, Drogas de síntesis, Innovaciones, Factor de riesgo, Efectos, Salud, Enfermedad, Toxicidad
Drogodependencias, Drogas ilegales, Drogas de síntesis, Innovaciones, Factor de riesgo, Efectos, Salud, Enfermedad, Toxicidad
Ítems similars: Harms of synthetic cannabinoid receptor agonists (SCRAs) and their management
- The impact of changes in UK classification of the synthetic cannabinoid receptor agonists in 'Spice'
- Synthetic cannabinoids in Europe
- Acute toxicity due to the confirmed consumption of synthetic cannabinoids: clinical and laboratory findings
- Increases in synthetic cannabinoids-related harms: Results from a longitudinal web-based content analysis
- REPORT ON THE RISK ASSESSMENT OF GHB IN THE FRAMEWORK OF THE JOINT ACTION ON NEW SYNTHETIC DRUGS
- REPORT ON THE RISK ASSESSMENT OF PMMA IN THE FRAMEWORK OF THE JOINT ACTION ON NEW SYNTHETIC DRUGS